FindTrial
Sign In

Traditional Chinese Medicine for novel coronavirus pneumonia (COVID-19)

Clinical study for TCM Decoction in the treatment of novel coronavirus pneumonia (COVID-19)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030864
Enrollment
Unknown
Registered
2020-03-16
Start date
2020-02-01
Completion date
Unknown
Last updated
2020-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Case series:Western medicine plus Qingfei Paidu decoction

Sponsors

Xiangyang 1st people's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. novel coronavirus pneumonia diagnostic criteria; 2. age unlimited, male and female unlimited.

Exclusion criteria

Exclusion criteria: 1. not qualified for novel coronavirus pneumonia diagnostic criteria; 2. Pregnant or lactating women who are allergic to the drug; 3. Patients with severe primary diseases and psychosis, such as cardiovascular, liver, kidney and hematopoietic system; 4. There are factors influencing the observation of curative effect; 5. Those who do not meet the inclusion criteria, fail to use the medicine according to the regulations, fail to determine the curative effect or incomplete data, which affect the judgment of curative effect or safety.

Design outcomes

Primary

MeasureTime frame
2019-ncov-RNA;Chest CT;Routine blood test;Blood biochemistry;TCM symptom;—

Countries

China

Contacts

Public ContactZhu Bo

Xiangyang 1st People's Hospital

274770142@qq.com+86 13995789500

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026